Improving care for older adults receiving radiation therapy
Improving Outcomes for Older Adults Undergoing Radiation Therapy: Prospective Cohort Study
This study is trying to see how radiation therapy affects older adults with cancer to help improve their care and treatment experience.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 225 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05721053 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance the healthcare experience for individuals aged 65 and older who are undergoing radiation therapy for cancer. It will assess patients' ability to complete their treatment, monitor changes in daily functioning, and evaluate self-reported side effects through surveys and assessments at multiple timepoints: before treatment, at the end of treatment, and during follow-ups at 1, 3, and 6 months. The findings will provide valuable insights for radiation oncologists to improve future patient care.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 65 and older with pathologically confirmed cancer who are receiving radiation therapy at Mount Sinai facilities.
Not a fit: Patients who are younger than 65 or do not have a confirmed cancer diagnosis will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment outcomes and quality of life for older adults undergoing radiation therapy.
How similar studies have performed: While there may be similar studies focusing on older adults and cancer treatment, this specific approach to improving radiation therapy outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient must be ≥ 65 years * Patient must have pathologically confirmed cancer * Patient must have the ability to provide informed consent, or have a legally authorized representative (LAR) present to provide informed consent on the participant's behalf * Must be radiation oncology patient at Mount Sinai Hospital, Mount Sinai Downtown, or Mount Sinai West. Exclusion Criteria: * There is no exclusion criteria
Where this trial is running
New York, New York
- One Gustave L Levy Place — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Kavita Dharmarajan, MD, MSc — Icahn School of Medicine at Mount Sinai
- Study coordinator: Vanessa Jimenez
- Email: vanessa.jimenez@mountsinai.org
- Phone: (212) 824-7325
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.